122 related articles for article (PubMed ID: 1589731)
1. Ceftazidime as initial therapy in febrile patients with acute leukemia during induction chemotherapy. Leukemia Group of Middle Sweden.
Samuelsson J; Lönnqvist B; Palmblad J; Grimfors G; Järnmark M; Lerner R; Ljungman P; Nyström-Rosander C; Oberg G
Scand J Infect Dis; 1992; 24(1):89-96. PubMed ID: 1589731
[TBL] [Abstract][Full Text] [Related]
2. Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
Fanci R; Paci C; Martinez RL; Fabbri A; Pecile P; Leoni F; Longo G
J Chemother; 2000 Jun; 12(3):232-9. PubMed ID: 10877519
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of piperacillin and ciprofloxacin as initial therapy for fever in severely neutropenic leukemia patients.
Samuelsson J; Nilsson PG; Wahlin A; Lerner R; Winqvist I; Palmblad J
Scand J Infect Dis; 1992; 24(4):467-75. PubMed ID: 1411313
[TBL] [Abstract][Full Text] [Related]
4. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of empirical antibiotic therapy in the control of infections in patients with acute leukemia during severe neutropenia].
Hansz J; Woźny T; Bajko G; Drozdowska D
Pol Arch Med Wewn; 1992 Jun; 87(6):379-85. PubMed ID: 1408996
[TBL] [Abstract][Full Text] [Related]
6. Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients.
Aparicio J; Oltra A; Llorca C; Montalar J; Herranz C; Gómez-Codina J; Pastor M; Munárriz B
Eur J Cancer; 1996 Sep; 32A(10):1739-43. PubMed ID: 8983283
[TBL] [Abstract][Full Text] [Related]
7. Use of ceftazidime in febrile incidents in immunocompromised haematological patients.
d'Oliveira JJ; Pereira ME; Mateus LM; Monteiro JM; Parreira AS; Soares AD
J Int Med Res; 1986; 14(1):30-4. PubMed ID: 3514313
[TBL] [Abstract][Full Text] [Related]
8. Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes.
Todeschini G; Veneri D; Carlini S; Pizzolo G; Ambrosetti A; Bonesi R; Cassibba V; Vinante F; Meneghini V; Perona G
Hematol Oncol; 1991; 9(3):137-46. PubMed ID: 1937406
[TBL] [Abstract][Full Text] [Related]
9. Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer.
Fleischhack G; Hartmann C; Simon A; Wulff B; Havers W; Marklein G; Hasan C; Bode U
J Antimicrob Chemother; 2001 Jun; 47(6):841-53. PubMed ID: 11389117
[TBL] [Abstract][Full Text] [Related]
10. Ceftazidime as first-line therapy for fever in acute leukaemia.
Donnelly JP; Marcus RE; Goldman JM; Cohen J; Worsley AM; Catovsky D; Darrell JH; Want SV; Galton DA
J Infect; 1985 Nov; 11(3):205-15. PubMed ID: 3910730
[TBL] [Abstract][Full Text] [Related]
11. Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen.
J Antimicrob Chemother; 1995 Jul; 36(1):185-200. PubMed ID: 8537265
[TBL] [Abstract][Full Text] [Related]
12. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
Freifeld AG; Walsh T; Marshall D; Gress J; Steinberg SM; Hathorn J; Rubin M; Jarosinski P; Gill V; Young RC
J Clin Oncol; 1995 Jan; 13(1):165-76. PubMed ID: 7799016
[TBL] [Abstract][Full Text] [Related]
13. Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia.
Daenen S; Erjavec Z; Uges DR; De Vries-Hospers HG; De Jonge P; Halie MR
Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):188-92. PubMed ID: 7614958
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
Hess U; Böhme C; Rey K; Senn HJ
Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
[TBL] [Abstract][Full Text] [Related]
15. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.
Chuang YY; Hung IJ; Yang CP; Jaing TH; Lin TY; Huang YC
Pediatr Infect Dis J; 2002 Mar; 21(3):203-9. PubMed ID: 12005083
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
Mustafa MM; Carlson L; Tkaczewski I; McCracken GH; Buchanan GR
Pediatr Infect Dis J; 2001 Mar; 20(3):362-9. PubMed ID: 11303851
[TBL] [Abstract][Full Text] [Related]
17. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
Med Klin (Munich); 1994 Mar; 89(3):114-23. PubMed ID: 8196571
[TBL] [Abstract][Full Text] [Related]
18. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S
Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473
[TBL] [Abstract][Full Text] [Related]
19. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.
Feld R; DePauw B; Berman S; Keating A; Ho W
J Clin Oncol; 2000 Nov; 18(21):3690-8. PubMed ID: 11054442
[TBL] [Abstract][Full Text] [Related]
20. An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group.
Höffken G; Pasold R; Pflüger KH; Finke J; Fauser AA; Szelenyi H; Wagner J
J Antimicrob Chemother; 1999 Sep; 44(3):367-76. PubMed ID: 10511404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]